Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Persistent lymphoedema in Morbihan disease : formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis

Identifieur interne : 000380 ( PascalFrancis/Checkpoint ); précédent : 000379; suivant : 000381

Persistent lymphoedema in Morbihan disease : formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis

Auteurs : T. Nagasaka [Japon] ; T. Koyama [Japon] ; K. Matsumura [Japon] ; K. R. Chen [Japon]

Source :

RBID : Pascal:08-0487951

Descripteurs français

English descriptors

Abstract

Morbihan disease is a rare complication of rosacea, characterized by persistent lymphoedema on the upper half of the face, occurring during the chronic clinical course of rosacea. This refractory condition has been also designated as 'rosacea lymphoedema' and 'solid persistent facial oedema of rosacea'. We report a patient with Morbihan disease showing persistent lymphoedema on the upper half of the face accompanied by unique histological findings of striking dermal dilated lymphatics and damage of the lymphatics at the site of the adjacent epithelioid cell granulomas, with histiocytes bulging into the lymphatic lumen. The marked epithelioid cell granulomas forming around dermal lymphatic vessels with subsequent lymphatic damage and luminal obstruction by histiocytic infiltration may account for the development of lymphoedema in this patient.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:08-0487951

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Persistent lymphoedema in Morbihan disease : formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis</title>
<author>
<name sortKey="Nagasaka, T" sort="Nagasaka, T" uniqKey="Nagasaka T" first="T." last="Nagasaka">T. Nagasaka</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koyama, T" sort="Koyama, T" uniqKey="Koyama T" first="T." last="Koyama">T. Koyama</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Matsumura, K" sort="Matsumura, K" uniqKey="Matsumura K" first="K." last="Matsumura">K. Matsumura</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, K R" sort="Chen, K R" uniqKey="Chen K" first="K. R." last="Chen">K. R. Chen</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">08-0487951</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0487951 INIST</idno>
<idno type="RBID">Pascal:08-0487951</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000367</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000593</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000380</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000380</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Persistent lymphoedema in Morbihan disease : formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis</title>
<author>
<name sortKey="Nagasaka, T" sort="Nagasaka, T" uniqKey="Nagasaka T" first="T." last="Nagasaka">T. Nagasaka</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koyama, T" sort="Koyama, T" uniqKey="Koyama T" first="T." last="Koyama">T. Koyama</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Matsumura, K" sort="Matsumura, K" uniqKey="Matsumura K" first="K." last="Matsumura">K. Matsumura</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chen, K R" sort="Chen, K R" uniqKey="Chen K" first="K. R." last="Chen">K. R. Chen</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<placeName>
<settlement type="city">Tokyo</settlement>
<region type="région">Région de Kantō</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Clinical and experimental dermatology : (Print)</title>
<title level="j" type="abbreviated">Clin. exp. dermatol. : (Print)</title>
<idno type="ISSN">0307-6938</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Clinical and experimental dermatology : (Print)</title>
<title level="j" type="abbreviated">Clin. exp. dermatol. : (Print)</title>
<idno type="ISSN">0307-6938</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Dermatology</term>
<term>Disease</term>
<term>Epithelioid cell</term>
<term>Formation</term>
<term>Granuloma</term>
<term>Lymphedema</term>
<term>Morbihan</term>
<term>Pathogenesis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Lymphoedème</term>
<term>Morbihan</term>
<term>Maladie</term>
<term>Formation</term>
<term>Cellule épithélioïde</term>
<term>Granulome</term>
<term>Pathogénie</term>
<term>Dermatologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Morbihan disease is a rare complication of rosacea, characterized by persistent lymphoedema on the upper half of the face, occurring during the chronic clinical course of rosacea. This refractory condition has been also designated as 'rosacea lymphoedema' and 'solid persistent facial oedema of rosacea'. We report a patient with Morbihan disease showing persistent lymphoedema on the upper half of the face accompanied by unique histological findings of striking dermal dilated lymphatics and damage of the lymphatics at the site of the adjacent epithelioid cell granulomas, with histiocytes bulging into the lymphatic lumen. The marked epithelioid cell granulomas forming around dermal lymphatic vessels with subsequent lymphatic damage and luminal obstruction by histiocytic infiltration may account for the development of lymphoedema in this patient.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0307-6938</s0>
</fA01>
<fA02 i1="01">
<s0>CEDEDE</s0>
</fA02>
<fA03 i2="1">
<s0>Clin. exp. dermatol. : (Print)</s0>
</fA03>
<fA05>
<s2>33</s2>
</fA05>
<fA06>
<s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Persistent lymphoedema in Morbihan disease : formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>NAGASAKA (T.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>KOYAMA (T.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>MATSUMURA (K.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>CHEN (K. R.)</s1>
</fA11>
<fA14 i1="01">
<s1>Department of Dermatology, Saiseikai Central Hospital</s1>
<s2>Tokyo</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>764-767</s1>
</fA20>
<fA21>
<s1>2008</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>16224</s2>
<s5>354000196076060200</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2008 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>12ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>08-0487951</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Clinical and experimental dermatology : (Print)</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Morbihan disease is a rare complication of rosacea, characterized by persistent lymphoedema on the upper half of the face, occurring during the chronic clinical course of rosacea. This refractory condition has been also designated as 'rosacea lymphoedema' and 'solid persistent facial oedema of rosacea'. We report a patient with Morbihan disease showing persistent lymphoedema on the upper half of the face accompanied by unique histological findings of striking dermal dilated lymphatics and damage of the lymphatics at the site of the adjacent epithelioid cell granulomas, with histiocytes bulging into the lymphatic lumen. The marked epithelioid cell granulomas forming around dermal lymphatic vessels with subsequent lymphatic damage and luminal obstruction by histiocytic infiltration may account for the development of lymphoedema in this patient.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B08</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B12B04</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Morbihan</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Morbihan</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Morbihán</s0>
<s2>NG</s2>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Maladie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Disease</s0>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Enfermedad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Formation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Formation</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Formación</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Cellule épithélioïde</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Epithelioid cell</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Célula epitelioide</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Granulome</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Granuloma</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Granuloma</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Pathogénie</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Pathogenesis</s0>
<s5>14</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Patogenia</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Dermatologie</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Dermatology</s0>
<s5>15</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Dermatología</s0>
<s5>15</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Bretagne</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Bretagne</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Bretagne</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>France</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>France</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Francia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Europe</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Europa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Pathologie de l'appareil circulatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fN21>
<s1>316</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>Japon</li>
</country>
<region>
<li>Région de Kantō</li>
</region>
<settlement>
<li>Tokyo</li>
</settlement>
</list>
<tree>
<country name="Japon">
<region name="Région de Kantō">
<name sortKey="Nagasaka, T" sort="Nagasaka, T" uniqKey="Nagasaka T" first="T." last="Nagasaka">T. Nagasaka</name>
</region>
<name sortKey="Chen, K R" sort="Chen, K R" uniqKey="Chen K" first="K. R." last="Chen">K. R. Chen</name>
<name sortKey="Koyama, T" sort="Koyama, T" uniqKey="Koyama T" first="T." last="Koyama">T. Koyama</name>
<name sortKey="Matsumura, K" sort="Matsumura, K" uniqKey="Matsumura K" first="K." last="Matsumura">K. Matsumura</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000380 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000380 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:08-0487951
   |texte=   Persistent lymphoedema in Morbihan disease : formation of perilymphatic epithelioid cell granulomas as a possible pathogenesis
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024